Pneumonia Vaccines Market to Reach $10.21 Bn, Globally, by 2025 at 5% CAGR: AMR

[In The News]

PORTLAND, Oregon, June 6, 2019 /PRNewswire/ -- Allied Market Research recently published a report, titled, Pneumonia Vaccine Market by Vaccine Type (Pneumococcal Conjugate Vaccine, and Pneumococcal Polysaccharide Vaccine), by Product Type (Prevnar 13, Synflorix, and Pneumovax 23) and By...

View the full article